chartexchange

Foghorn Therapeutics is cutting 40% of its workforce after Eli Lilly ends cancer drug partnership

Quartz | Oct 2, 2026 10:00 AM EDT


The companies are scrapping two collaborative cancer programs and don't anticipate any further joint projects

Read original article